bioMérieux S.A. (EPA:BIM)
113.70
+0.20 (0.18%)
Jan 8, 2026, 5:38 PM CET
bioMérieux Market Cap
bioMérieux has a market cap or net worth of €13.42 billion as of January 8, 2026. Its market cap has increased by 11.09% in one year.
Market Cap
13.42B
Enterprise Value
13.55B
Revenue
4.12B
Ranking
n/a
PE Ratio
35.87
Stock Price
€113.70
Market Cap Chart
Since July 7, 2004, bioMérieux's market cap has increased from 1.18B to 13.42B, an increase of 1,034.18%. That is a compound annual growth rate of 11.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 13.42B | 3.08% |
| Dec 31, 2025 | 13.02B | 6.63% |
| Dec 31, 2024 | 12.21B | 2.78% |
| Dec 29, 2023 | 11.88B | 2.52% |
| Dec 30, 2022 | 11.59B | -21.58% |
| Dec 31, 2021 | 14.78B | 8.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 121.47B |
| Sanofi | 98.79B |
| Sartorius Stedim Biotech | 20.86B |
| Eurofins Scientific SE | 12.17B |
| Ipsen | 9.93B |
| ABIVAX Société Anonyme | 8.08B |
| Virbac | 3.01B |
| emeis Société anonyme | 2.26B |